Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
-- Conference Call to be Hosted Today at 4:30 p.m. ET -- SEATTLE, Feb. 22 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today reported results for the year and quarter ended...
SEATTLE, Feb. 11 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) management will host a conference call on Monday, February 22, 2010 at 4:30 p.m. ET to review fourth quarter and...
SEATTLE, Feb. 3 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the 12th Annual BIO CEO and Investor Conference in New York City on...
SEATTLE, Jan. 5 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco...
SEATTLE, Dec. 11 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that the underwriters of its previously announced public offering have exercised in full their...
SEATTLE, Dec. 10 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that it has priced its underwritten public offering of 15,000,000 shares of its common stock at a...
- Seasoned Global Oncology Executive Joining Team, Expanding Company's Commercial Expertise - SEATTLE, Dec. 10 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that...
SEATTLE, Dec. 8 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that it has commenced an underwritten public offering, subject to market and other conditions, of...
SEATTLE, Nov. 25 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the following two investor conferences next month. NASDAQ OMX 23rd...
-- PDUFA Date Assigned as May 1, 2010 -- SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that the U.S. Food and Drug Administration (FDA) provided...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 729,72M |
| NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,54M |
| RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 338,75M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,29M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 234,8M |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
6
